Overview

Valsartan Optimal Therapy Against Elevated Home Blood Pressure Research(VOYAGER)Study

Status:
Completed
Trial end date:
2013-11-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to compare improvement percentage of urinary albumin excretion between valsartan 80 mg- and valsartan 160 mg-based therapy in patient with morning hypertension.
Phase:
Phase 4
Details
Lead Sponsor:
Kitakyushu-Tsuyazaki Hospital
Treatments:
Valsartan